The Philadelphia Eagles announced on Monday that quarterback Jalen Hurts will miss the remainder of the season after further testing identified blood clots that have travelled to his lungs.
Team medical staff said Hurts, 28, has been diagnosed with deep vein thrombosis and bilateral pulmonary emboli. He will receive anticoagulant therapy and, because of that treatment, is unable to participate in contact activities for the duration of his care. The club described his condition as stable and said he has no significant functional limitations.
Diagnosis and treatment
The Eagles said Hurts’s treatment plan centers on blood thinners to address the clots. Under anticoagulation therapy, players are generally restricted from on-field contact until cleared by team physicians, a factor that the team cited in its decision to rule him out for the rest of the season.
Team status and next steps
With Hurts sidelined, the Eagles have elevated backup Tanner McKee to the starting role. The team did not provide a timetable for Hurts’s return beyond the immediate restriction on contact activities; any decision about his future availability will depend on his response to treatment and medical evaluations.
The club released the medical update on Monday and did not provide additional detail about when Hurts first sought testing or how long he will remain on anticoagulants. The Eagles will proceed with their roster and game plans with McKee as the on-field quarterback while Hurts undergoes treatment and monitoring.